In this blog post, we will examine the controversy surrounding Monsanto and GMOs to determine whether the root of the problem lies in corporate ethics or in the inherent risks of genetic modification itself.

The Origins of the GMO Debate

GMO stands for Genetically Modified Organism, referring to organisms that have been recombined by altering their genetic sequences or adding new genes. Developed in earnest since the late 20th century, the use of GMOs has increased worldwide. In South Korea, according to 2014 data from the Ministry of Food and Drug Safety, the variety of imported genetically modified foods has grown significantly, indicating a widespread adoption of GMOs. The debate surrounding GMOs remains fierce. Proponents primarily advocate for research and commercialization based on practical reasons, such as increasing food production, while opponents argue that their use should be restricted or banned due to concerns about potential harm to human health and the environment.

Monsanto’s History and Key Cases

Monsanto is a company frequently mentioned in connection with GMOs today. Originally a chemical company that produced PCBs (polychlorinated biphenyls), it shifted its focus to herbicides and biotechnology, which shaped its current image. Among the products Monsanto has created, the most notable are Agent Orange, a defoliant used in the Vietnam War, and Roundup, a herbicide still widely used today.
Agent Orange is known for causing long-term health damage due to dioxin contamination, while Roundup contains the active ingredient glyphosate. Some studies and publications have raised concerns, reporting cellular damage, endocrine disruption, and lethal effects on amphibians when exposed during fetal and developmental stages. These cases have sparked ongoing debate regarding the safety of chemicals, including Roundup.
Another early genetically modified product from Monsanto was somatotropin (rBST), which stimulates milk production in cows. Although it was expected to be a solution for increasing milk supply, it became controversial as problems such as shortened lifespans and increased mastitis were reported in cows that received the treatment. Subsequently, Monsanto developed crops resistant to its own herbicides—so-called “Roundup Ready” varieties—and adopted a strategy of selling herbicides and seeds as a package.

Corporate Strategy and Its Impact on Farmers and Consumers

Monsanto’s business model can be summarized as selling herbicides and herbicide-resistant seeds as a package and collecting royalties through seed patents. This process led to friction with some scientists, and due to patent and contract terms, a system was established where farmers could not save part of their harvest as seed for the following year, forcing them to purchase seeds annually. Books and various reports point out that these commercial practices have undermined farmers’ economic autonomy and had a negative impact on small-scale farms.
Furthermore, it has been argued that the seed market restricted by patents and corporate commercial pressure led to attempts at deregulation, as well as the dismissal and lawsuits against scientists. These behaviors have been criticized not only as issues with the technology itself but also as matters of corporate ethics and legal and institutional frameworks.

Environmental Impacts and Issues of Gene Spread

Issues reported since the introduction of GM crops include the natural spread of genes—specifically, the “contamination” of native crops by GM genes—changes in soil and ecosystems, and the emergence of resistance to certain herbicides. These phenomena have resulted in the displacement of native varieties in some regions and raised concerns that excessive herbicide use could lead to soil degradation and a decline in biodiversity.
Over time, some GM crops have developed resistance to specific herbicides, requiring increased herbicide use; as a result, cases have been reported where various species have been affected and the ecological balance disrupted. Thus, the impact on the environment and agricultural ecosystems goes beyond a simple technical issue, carrying complex socio-economic implications.

The Scientific Community’s Response and Modern Safety Verification

On the other hand, some scientists believe that fears regarding GMOs are exaggerated. They argue that continuing GMO research can solve food security issues and that scientifically validated methods can produce safe varieties. In fact, as the number of crops with completed genetic maps has increased, targeted genetic modification has become possible, and technologies capable of reducing side effects compared to the initial random insertion methods have been developed.
Furthermore, safety assessment methods have become more diverse than in the past. With the introduction of long-term, multi-layered evaluations—such as studying the effects across multiple generations using not only laboratory rodents but also microorganisms and insects with rapid reproduction cycles—there is a view that modern GMOs undergo stricter verification than in the past.

Corporate Ethics and the Intrinsic Risks of GMOs

The book identifies Monsanto as a prime example of an unethical corporation, arguing that the company’s circumvention of regulations, suppression of scientists, and disregard for safety research are the root causes of many problems. In other words, not all adverse effects can be explained by the risks of the technology alone; corporate commercial motives and actions play a significant role.
Of course, it is also difficult to assert that genetic engineering technology itself is completely harmless. Early indiscriminate applications led to unintended side effects, and the impacts on the environment and health demonstrate the need for careful management and transparent research. The key point is that strict regulation, ethical management, and transparent safety verification are essential to reduce the risks of the technology.

Future Outlook and Conclusion

In the context of population growth and limited resources, increasing food production remains a major challenge. Given that natural evolution alone cannot keep pace with rising demand, genetic modification technology has the potential to be a significant solution. However, some argue that instead of the aggressive and indiscriminate interventions of the past, a more passive and targeted approach—one that respects the direction of natural evolution while efficiently supporting the process—is preferable.
The Monsanto case demonstrates, regardless of the technology’s inherent usefulness, just how crucial corporate ethics, regulation, and social consensus are. Recently, Monsanto’s market dominance is no longer as absolute as it once was, and there is a trend toward increased oversight by regulatory authorities and the public. In conclusion, GMOs can be a tool for a future free from hunger, but this requires responsible corporate behavior, transparent research, and strict regulation. The key is to harness the technology’s potential without repeating the mistakes of the past.